These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical applications of positron emission tomography. Maisey M Trans Med Soc Lond; 1992-1993; 109():52-61. PubMed ID: 1365497 [No Abstract] [Full Text] [Related]
4. Introduction to the physics of molecular imaging with radioactive tracers in small animals. King MA; Pretorius PH; Farncombe T; Beekman FJ J Cell Biochem Suppl; 2002; 39():221-30. PubMed ID: 12552621 [TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis. Blomqvist G Wien Klin Wochenschr; 1991; 103(15):451-7. PubMed ID: 1926871 [TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography: background, possibilities and perspectives in neuroscience. Paans AM Acta Neurol Belg; 1997 Sep; 97(3):150-3. PubMed ID: 9345585 [TBL] [Abstract][Full Text] [Related]
7. [Positron-emission tomography (PET)--a new diagnostic method. Physical and technical requirements]. Newiger H Aktuelle Radiol; 1993 May; 3(3):140-3. PubMed ID: 8518303 [TBL] [Abstract][Full Text] [Related]
8. [Biokinetics of radioactive tracers: reappraisal of various concepts in the light of positron emission tomography]. Depresseux JC Ann Radiol (Paris); 1984 Dec; 27(8):702-7. PubMed ID: 6335636 [No Abstract] [Full Text] [Related]
9. Pharmacokinetic considerations in the PET and SPECT evaluation of CNS receptors. Mazière B; Delforge J Q J Nucl Med; 1997 Jun; 41(2):119-26. PubMed ID: 9203851 [TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography: physics, instrumentation, and image analysis. Porenta G Wien Klin Wochenschr; 1994; 106(15):466-77. PubMed ID: 7941595 [TBL] [Abstract][Full Text] [Related]
11. [Use of brain SPECT imaging in the diagnosis of Wernicke-Korsakoff's encephalopathy]. Jover F; Jover R; Martínez A; Caballero O Rev Neurol; 2004 Sep 16-30; 39(6):597-8. PubMed ID: 15468004 [No Abstract] [Full Text] [Related]
12. [Methods in medicine: positron-emission tomography]. Haberkorn U; Ostertag H Dtsch Med Wochenschr; 1995 Dec; 120(51-52):1789-90. PubMed ID: 8549265 [No Abstract] [Full Text] [Related]
14. Clinical objectives, tracer constraints and technological requirements for in vivo imaging. Jones T Med Prog Technol; 1991; 17(3-4):211-8. PubMed ID: 1839852 [TBL] [Abstract][Full Text] [Related]
15. Relevance of PET/SPET tracers for cardiac neurotransmission. Voipio-Pulkki LM Nucl Med Biol; 1995 Nov; 22(8):1027-35. PubMed ID: 8998462 [No Abstract] [Full Text] [Related]
17. Cyclotrons, radionuclides, precursors, and demands for routine versus research compounds. Wolf AP Ann Neurol; 1984; 15 Suppl():S19-24. PubMed ID: 6611121 [TBL] [Abstract][Full Text] [Related]
18. Nuclear medicine in neurology and psychiatry. Costa DC; Pilowsky LS; Ell PJ Lancet; 1999 Sep; 354(9184):1107-11. PubMed ID: 10509515 [TBL] [Abstract][Full Text] [Related]
19. [Principles of positron emission tomography]. Ostertag H Z Gastroenterol Verh; 1989 Jul; 24():150-1. PubMed ID: 2474933 [No Abstract] [Full Text] [Related]